ACOMO NV EO-,45/ NL0000313286 /
| 2024-06-05 8:09:59 AM | Chg. +0.120 | Volume | Bid1:22:27 PM | Ask1:22:27 PM | High | Low |
|---|---|---|---|---|---|---|
| 17.420EUR | +0.69% | 0 Turnover: 0.000 |
17.400Bid Size: 200 | 17.420Ask Size: 200 | 17.420 | 17.420 |
GlobeNewswire
1:35 PM
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
Newsfile Corp
1:30 PM
Appia Begins Uranium Exploration Season with Ground Reconnaissance at "Eastside" Project, Saskatchew...
GlobeNewswire
1:30 PM
Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That H...
GlobeNewswire
1:30 PM
Ocean Power Technologies Awarded Contract for Immediate Delivery of Unmanned Surface Vehicle to Offs...
GlobeNewswire
1:30 PM
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Es...
GlobeNewswire
1:30 PM
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:29 PM
Telix Announces Launch of Proposed Initial Public Offering in the United States
GlobeNewswire
1:28 PM
Ollie’s Bargain Outlet Announces Executive Promotions and Appointments as Part of Anticipated Leader...
GlobeNewswire
1:05 PM
Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders
GlobeNewswire
1:05 PM
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Dev...
GlobeNewswire
1:01 PM
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...
GlobeNewswire
1:00 PM
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
1:00 PM
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
